Peptide overview

GLP-1 receptor agonist — approved, prescription-only.

Also known as: Ozempic, Wegovy, Rybelsus

Dual GIP/GLP-1 receptor agonist — approved, prescription-only.

Also known as: Mounjaro, Zepbound

Triple agonist (GIP/GLP-1/glucagon) — in clinical testing, NOT approved.

Also known as: LY3437943

HGH fragment — clinically investigated, but not approved as a weight-loss medication.

Also known as: HGH-Fragment 176-191, Anti-Obesity Drug 9604

GHRH analogue — approved prescription-only in the USA (HIV lipodystrophy).

Also known as: Egrifta

Not a peptide but an NNMT inhibitor — fat-metabolism research without human data.

Also known as: 5-Amino-1-Methylquinolinium, NNMT-Inhibitor

Synthetic peptide — predominantly animal data, NOT approved for humans.

Also known as: Body Protection Compound 157, PL 14736 (verwandt)

Actin-binding peptide — research substance, NOT approved.

Also known as: TB-500, Thymosin Beta-4, Tβ4

An anti-inflammatory tripeptide from the α-MSH terminus — gut and research focus, not approved.

Also known as: Lysin-Prolin-Valin, α-MSH(11-13)

Growth hormone secretagogues — research peptides, not approved for humans.

Also known as: Modified GRF (1-29), GHRH-Analogon + GHRP, Ipamorelin

GHRH analogue — was approved as Geref, today no approved finished medicinal product.

Also known as: Geref, GHRH (1-29), Sermorelin-Acetat

Synthetic ghrelin mimetic — traded as a research substance, banned in sport.

Also known as: Pralmorelin, KP-102, Growth Hormone Releasing Peptide-2

The first GH-releasing peptide — a strong appetite trigger, not approved.

Also known as: Growth Hormone Releasing Peptide-6, SKF-110679

The strongest GH releaser of the GHRP group — with desensitization and cardiac research.

Also known as: Examorelin, HEX

The real recombinant growth hormone — approved, prescription-only, banned in sport.

Also known as: rhGH, Genotropin, Norditropin

Neuropeptide — registered as a medicine in Russia, not approved in the EU/USA.

Also known as: ACTH(4-7)-Analogon, Heptapeptid

Anxiolytic neuropeptide (tuftsin analogue) — registered in Russia, not approved in the EU/USA.

Also known as: TP-7, Tuftsin-Analogon

A neuropeptide with contradictory sleep evidence — not approved.

Also known as: Delta Sleep-Inducing Peptide, Delta-Schlaf-induzierendes Peptid

Copper-binding tripeptide — established in topical cosmetics.

Also known as: Kupfer-Tripeptid-1, Copper Peptide, Glycyl-L-Histidyl-L-Lysin:Cu

Cosmetic peptide — topical in anti-aging formulations.

Also known as: Acetyl Hexapeptide-3, Acetyl Hexapeptide-8

Cosmetic matrikines — topical to stimulate collagen formation.

Also known as: Palmitoyl Pentapeptide-4, Palmitoyl Tripeptide-1, Palmitoyl Tetrapeptide-7

Melanocortin agonist for sexual desire — approved in the USA as Vyleesi.

Also known as: Bremelanotid, Vyleesi, PT-141

A tanning peptide without approval — with documented melanoma and priapism cases.

Also known as: MT-II, MT-2

Approved as an implant (Scenesse) — but only for the rare light disease EPP, not for tanning.

Also known as: Afamelanotid, Scenesse, MT-1

Synthetic tetrapeptide — research substance for aging, not approved.

Also known as: Epithalon, AEDG, Ala-Glu-Asp-Gly

Immunomodulating peptide — approved as Zadaxin in several countries, not FDA-approved.

Also known as: Tα1, Zadaxin, Thymalfasin

A mitochondrially encoded peptide — an "exercise mimetic" of research, not approved.

Also known as: MOTSc, Mitochondrial ORF of the 12S rRNA type-c

A cardiolipin-stabilizing mitochondrial peptide — approved in the USA for Barth syndrome in 2025.

Also known as: Elamipretid, Bendavia, MTP-131